hotspot -WSS

hotspot

author：entertainment 2025-10-01 04:32:42 - browse：5

STAT's Damian Garde speaks with Mikael Dolsten and Mathai Mammen, in New York on March 21, 2024 — From left to right, STAT's Damian Garde; Mikael Dolsten, chief scientific officer of Pfizer research and development; and Rose Loughlin, Moderna’s senior vice president of early research and development, discuss the future of pharma at the STAT 2024 Breakthrough Summit East. STAT

Drug development is more of a sprint than a marathon these days, thanks to more and better ways to target underlying biology and a more nuanced interpretation of precision medicine, three biotech leaders said at the STAT Breakthrough Summit East in New York Thursday.

“We used to say, well, you may spend five years in the research phase, another five in development. Now I see a project that takes one year of research, from an idea to studies,” said Mikael Dolsten, chief scientific officer and president of Pfizer research and development. “Time is life. You care about patients. And when the distance to run is long, it holds back the energy and the inspiration.”

Key to that success are transformative new technologies like messenger RNA, which powered vaccines developed by Pfizer with its partner BioNTech.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Biogen shutters digital health group, ends Apple study, in cost cutting move

entertainment

WSS

Sudafed saga points to U.S. issues with evaluating older drugs

How one patient went off dialysis — and others can too

Did you have Obamacare on your GOP debate bingo card?

Sudafed saga points to U.S. issues with evaluating older drugs

Albert Bourla of Pfizer: worst biopharma CEO of 2023

Keeping primary care docs in field isn't impossible, says AAFP CEO

entertainment

hotspot

entertainment

Walensky prepares to leave CDC — and Congress — behind

Ionis has late

Jerome Adams on the need for new antivirals for Covid

Sudafed saga points to U.S. issues with evaluating older drugs

Activists slam private health insurers over coverage restrictions

Health tech startups drop sharply from 2021 highs

Anesthesiologist group: stop taking Ozempic before surgery

Christmas in the PICU brings some surprising joy

Jerome Adams on the need for new antivirals for Covid

SNAP should offer more nutrition education

explore

https://cbu01.alicdn.com/img/ibank/2017/789/736/4067637987_1236373560.220x220xz.jpg

Mindstrong's demise and the future of mental health care

How to keep neuroscience’s past racism from being its future

Kaiser Permanente unions announce official strike date

HCA sued by state AG for quality issues at Mission Health

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

hotspot

explore

entertainment

hotspot